Westchester Capital Management (New York)’s OneMedNet ONMD Stock Holding History

Westchester Capital Management (New York)’s Portfolio ONMD Stock Details ONMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-228,588	Closed	-$2.59M	–	288
2023 Q3	$2.59M	Sell	228,588 -178,412	-44%	-$1.99M	0.08%	168
2023 Q2	$4.45M	Hold	407,000	–	–	0.14%	152
2023 Q1	$4.35M	Sell	407,000 -100,000	-20%	-$1.06M	0.13%	193
2022 Q4	$5.29M	Buy	+507,000	New	+$5.29M	0.15%	161

Other funds holding ONMD

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

EWA

Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return

FFL

Future Fund LLC Chicago, Illinois $284M AUM 28.58% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Westchester Capital Management (New York)'s ONMD Position: Q4 2023 in Review

Westchester Capital Management (New York) sold out of OneMedNet (ONMD) in Q4 2023, closing a stake of 228,588 shares — an estimated $2.59M sold.

Westchester Capital Management (New York) first reported a position in ONMD in Q4 2022 and held it in 4 quarters. The position peaked at $5.29M in Q4 2022. 6 funds tracked by Wall St. Rank hold ONMD as of Q4 2023.

Westchester Capital Management (New York) reported no remaining OneMedNet position as of Q4 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 228,588 OneMedNet shares in Q4 2023, an estimated $2.59M.
Westchester Capital Management (New York) first reported a position in OneMedNet in Q4 2022 and held it in 4 quarters.
Westchester Capital Management (New York)'s OneMedNet position peaked at $5.29M in Q4 2022.
6 funds tracked by Wall St. Rank held OneMedNet as of Q4 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2023, filed 15 Feb 2024.